NEW YORK (GenomeWeb News) – Cepheid today announced that the US Food and Drug Administration has cleared the company's updated Xpert MRSA/SA Blood Culture test running on the GeneXpert system.

The test detects methicillin-resistant Staphylococcus aureus and Staphylococcus aureus in blood culture bottles indicating gram-positive cocci in clusters to determine whether a patient's blood is infected with either bacterium, which are frequent causes of sepsis in hospitalized patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.